| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,437 |
2,857 |
$131K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,021 |
885 |
$47K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,621 |
1,313 |
$21K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
490 |
439 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
969 |
457 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
997 |
838 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
783 |
657 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
953 |
798 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15 |
12 |
$801.39 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
509 |
422 |
$614.73 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,045 |
858 |
$310.96 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
163 |
130 |
$228.35 |
| 86308 |
|
58 |
49 |
$223.43 |
| 81003 |
|
144 |
130 |
$128.96 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
161 |
148 |
$0.00 |
| 1036F |
|
187 |
163 |
$0.00 |
| 36416 |
|
32 |
30 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
374 |
321 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
740 |
604 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
79 |
70 |
$0.00 |